An Overview of Light Chain Multiple Myeloma: Clinical Characteristics and Rarities, Management Strategies, and Disease Monitoring.

Rafae, Abdul; Malik, Mustafa N; Abu Zar, Muhammad; Durer, Seren; Durer, Ceren

Rafae, Abdul; Malik, Mustafa N; Abu Zar, Muhammad; Durer, Seren; Durer, Ceren.

Afiliación

Rafae A; Hematology and Oncology, The University of Arizona, Tucson, USA.
Malik MN; Hematology and Oncology, The University of Arizona, Tucson, USA.
Abu Zar M; Hematology and Oncology, The University of Arizona, Tucson, USA.
Durer S; Hematology and Oncology, University of Arizona, Tucson, USA.
Durer C; Hemtology and Oncology, The University of Arizona, Tucson, USA.

Cureus ; 10(8): e3148, 2018 Aug 15.

Article en En | MEDLINE | ID: mdl-30345204

Palabras clave

bortezomib; light chain only multiple myeloma; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cureus Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google